Rapid LC-TOFMS method for identification of binding sites of covalent acylglucuronide-albumin complexes

Journal of Pharmaceutical and Biomedical Analysis

Volumn 31, Issue 6, 2003, Pages 1167-1176

  Ohkawa, T ^a   Norikura, R ^a   Yoshikawa, T ^a  

^a SHIONOGI AND CO LTD   (Japan)

Author keywords

Acylglucuronide; Covalent binding site; Delta bilirubin; LC TOFMS

Indexed keywords

BILIRUBIN; GLUCURONIC ACID; HUMAN SERUM ALBUMIN; IMINE; LIGAND; LYSINE; PEPTIDE; TRYPSIN;

AMINO ACID SEQUENCE; ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CONTROLLED STUDY; COVALENT BOND; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; RADIOACTIVITY; RAT; TANDEM MASS SPECTROMETRY;

EID: 0037430826     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(02)00733-1     Document Type: Article

References (18)

1. Faed E.M. Properties of acylglucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metab. Rev. 15:1984;1213-1249.
2. Ding A., Zia-Amirhosseini P., McDonagh A.F., Burlingame A.L., Benet L.Z. Reactivity of tolmetin glucuronide with human serum albumin: identification of binding sites and mechanisms of reaction by tandem mass spectrometry. Drug Metab. Dispos. 23:1995;369-376.
3. Qui Y., Burlingame A.L., Benet L.Z. Mechanisms for covalent binding of benoxaprofen glucuronide to human serum albumin: studied by tandem mass spectrometry. Drug Metab. Dispos. 26:1998;246-256.
4. Spahn-Langguth H., Benet L.Z. Acylglucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metab. Rev. 24:1992;5-48.
5. Zia Amirhosseini P., Harris R.Z., Brodsky F.M., Benet L.Z. Hypersensitivity to nonsteroidal anti-inflammatory drugs. Nat. Med. 1:1995;2-4.
6. Boelsterli U.A., Zimmerman H.J., Kretz R.A. Idiosyncratic liver toxicity of nonsteroidal anti-inflammatory drugs: molecular mechanisms and pathology. Crit. Rev. Toxicol. 25:1995;207-235.
7. van Breemen R.B., Fenselau C., Mogilevsky W., Odell G.B. Reaction of bilirubin glucuronide with serum albumin. J. Chromatogr. 383:1986;387-392.
8. McDonagh A.F., Palma L.A., Lauff J.J., Wu T.W. Origin of mammalian biliprotein and rearrangement of bilirubin glucuronides in vivo in the rat. J. Clin. Invest. 74:1984;763-770.
9. van Breemen R.B., Fenselau C. Acylation of albumin by 1-O-acylglucuronides. Drug Metab. Dispos. 13:1985;318-320.
10. Wells D.S., Janssen F.W., Ruelius H.W. Interactions between oxaprozin glucuronide and human serum albumin. Xenobiotica. 17:1987;1437-1449.
11. Ruelius H.W., Kirkman S.K., Young E.M., Janssen F.W. Reactions of oxaprozin-1-O-acylglucuronide in solutions of human plasma and albumin. Adv. Exp. Med. Biol. 197:1986;431-441.
12. Smith P.C., Benet L.Z., McDonagh A.F. Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff-base mechanism. Drug Metab. Dispos. 18:1990;639-644.
13. Smith P.C., McDonagh A.F., Benet L.Z. Irreversible binding of zomepirac to plasma protein in in vitro and in vivo. J. Clin. Invest. 77:1986;934-939.
14. Ding A., Ojingwa J.C., McDonagh A.F., Burlingame A.L., Benet L.Z. Evidence for covalent binding of acylglucuronides to serum albumin via the imine mechanism as revealed by tandem mass spectrometry. Proc. Natl. Acad. Sci. USA. 90:1993;3797-3801.
15. J.E. Hodge, The Amadori rearrangement, Adv. Carbohydr. Res. 10 (1955) 169-206.
16. Yoshida H., Inagaki T., Hirano M., Sugimoto T. Analyses of azopigments obtained from the delta fraction of bilirubin from mammalian plasma (mammalian biliprotein). Biochem. J. 248:1987;79-84.
17. Garlick R.L., Mazer J.S. The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J. Biol. Chem. 258:1983;6142-6146.
18. Iberg N., Flückiger R. Nonenzymatic glycosylation of albumin in vivo. J. Biol. Chem. 261:1986;13542-13545.